👦 Update On Little Fighter KENZO 👦

Little Fighter Kenzo Phillips was diagnosed with Acute Lymphoblastic Leukaemia (ALL) in February 2016, at a mere 8 months of age. Kenzo has gone through much in his short lifespan, including harsh chemotherapy treatments, and has seen more hospitals and doctors than any child should… Earlier this month LFCT celebrated with Kenzo and his family at […]

Read more
Pioneering Genetic Therapy Cures One-Year-Old of Acute Lymphoblastic Leukaemia (ALL)

A one-year-old girl, tiny Layla Richards, has become the first person in the world to receive a “designer” immune cell therapy to cure her aggressive “incurable” cancer. Layla was a mere 14-weeks-old when her mother, Lisa Foley, noticed that Layla’s heart was beating rather fast and that she was constantly crying and hardly eating. Doctors […]

Read more
Are we Close to a Cure for Leukaemia?

Leukaemia is a cancer that occurs when abnormal blood stem cells (immature white blood cells) are produced in the bone marrow. Normally white cells develop, repair and reproduce in an orderly fashion. The leukaemia cells do not mature, and therefore are not able to function as immune cells, but they keep on dividing in the […]

Read more
Researchers Identify Gene Mutation That Raises Risk Of Nerve Damage in Leukaemia Patients Using Vincristine

Important research from St. Jude Children’s Research Hospital regarding the use of the anti-cancer drug Vincristine, often used for treating Acute Lymphoblastic Leukaemia (ALL)   Researchers from St. Jude Children’s Research Hospital have identified the first genetic variation that is associated with increased risk and severity of peripheral neuropathy following treatment with a widely used anti-cancer drug. Investigators also […]

Read more